Qiu L - Search Results

1

Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis.

Luo C, Li Y, Liu W, Feng H, Wang H, Huang X, Qiu L, Ouyang J. Luo C, et al. Among authors: qiu l. J Neuroimmunol. 2013 Mar 15;256(1-2):55-61. doi: 10.1016/j.jneuroim.2012.12.001. Epub 2013 Jan 8. J Neuroimmunol. 2013. PMID: 23305745

2

[Analysis of prognostic factors and efficacy of plasmapheresis in the treatment of myasthenia crisis].

Feng HY, Liu WB, Qiu L, He XT, Zhang Y, Huang X, Huang RX. Feng HY, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2010 Dec 21;90(47):3343-6. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21223750 Chinese.

3

[Study of incidence and correlation factors of depression, anxiety and insomnia in patients with myasthenia gravis].

Qiu L, Feng HY, Huang X, Mo R, Ou CY, Luo CM, Li Y, Liu WB. Qiu L, et al. Zhonghua Yi Xue Za Zhi. 2010 Dec 7;90(45):3176-9. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21223762 Chinese.

4

[Correlation study between Chinese myasthenia gravis patients from Guangdong province and the polymorphism of HLA immunogene].

Feng HY, Luo M, Liu WB, Xiao LL, Qiu L, Huang X, Huang RX. Feng HY, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2011 May 10;91(17):1153-6. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21756765 Chinese.

5

A retrospective review of 15 patients with familial myasthenia gravis over a period of 25 years.

Feng HY, Liu WB, Luo CM, Yang LX, Fang W, Qiu L, Huang X, Li Y, Huang RX. Feng HY, et al. Among authors: qiu l. Neurol Sci. 2012 Aug;33(4):771-7. doi: 10.1007/s10072-011-0818-7. Epub 2011 Nov 5. Neurol Sci. 2012. PMID: 22057263

6

[Therapeutic efficacy and safety of tacrolimus for intractable myasthenia gravis: a report of 36 patients].

Feng HY, Liu WB, Qiu L, Huang X, Huang RX. Feng HY, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2011 Dec 6;91(45):3190-2. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22333101 Clinical Trial. Chinese.

7

[Response to thymectomy and analysis of influencing factors in the treatment of children with myasthenia gravis].

Li Y, Liu WB, Luo CM, Feng HY, Huang X, Wang HY, Qiu L, Huang RX. Li Y, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2012 May 8;92(17):1170-3. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22883003 Chinese.

8

[Efficacy and safety of low-dose cyclophosphamide plus corticosteroids for type I/II myasthenia gravis].

Feng HY, Liu WB, Huang X, Qiu L, Li Y, Wang HY, Luo CM. Feng HY, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2012 Sep 4;92(33):2323-6. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23158560 Clinical Trial. Chinese.

9

[Randomized controlled clinical trial of middle-dose cyclophosphamide plus methylprednisolone for myasthenia gravis patients in crisis].

Feng HY, Liu WB, Qiu L, Huang X, Luo CM, Li Y, Wang HY. Feng HY, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2012 Sep 18;92(35):2473-6. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23158712 Clinical Trial. Chinese.

10

[Clinical study and case follow-up of 61 cases of familial myasthenia gravis in 28 families].

Feng HY, Liu WB, Huang X, Qiu L, Li Y, Wang HY, Luo CM. Feng HY, et al. Among authors: qiu l. Zhonghua Yi Xue Za Zhi. 2012 Oct 9;92(37):2615-8. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23290062 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,846 results

Search Page

Filters